Dyne Therapeutics Inc (DYN) — Cash Flow-to-Debt Ratio
Dyne Therapeutics Inc (DYN) has a Cash Flow-to-Debt Ratio of -0.52x as of December 2025, meaning its operating cash flow of $-111.83 Million could theoretically repay -1% of its total liabilities ($214.83 Million) in one year. See DYN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dyne Therapeutics Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Dyne Therapeutics Inc across 19 annual periods. Also explore DYN net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dyne Therapeutics Inc (2007–2025)
Year-by-year debt coverage analysis for Dyne Therapeutics Inc. For market capitalisation and broader financial context, see Dyne Therapeutics Inc (DYN) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.88x | $-403.21 Million | $214.83 Million | ▲ +60.6% |
| 2024 | -4.76x | $-292.37 Million | $61.40 Million | ▼ -86.8% |
| 2023 | -2.55x | $-188.16 Million | $73.79 Million | ▲ +10.4% |
| 2022 | -2.85x | $-153.65 Million | $53.96 Million | ▼ -36.9% |
| 2021 | -2.08x | $-119.56 Million | $57.47 Million | ▲ +50.9% |
| 2020 | -4.24x | $-46.51 Million | $10.97 Million | ▲ +14.0% |
| 2019 | -4.93x | $-11.83 Million | $2.40 Million | ▼ -1456.8% |
| 2018 | -0.32x | $-4.16 Million | $13.15 Million | ▼ -634.4% |
| 2017 | 0.06x | $585.00 Million | $9.87 Billion | ▼ -3.5% |
| 2016 | 0.06x | $676.00 Million | $11.01 Billion | ▲ +462.9% |
| 2015 | 0.01x | $94.00 Million | $8.62 Billion | ▲ +244.4% |
| 2014 | -0.01x | $-62.00 Million | $8.21 Billion | ▼ -113.3% |
| 2013 | 0.06x | $175.00 Million | $3.08 Billion | ▲ +362.3% |
| 2012 | -0.02x | $-44.00 Million | $2.03 Billion | ▼ -226.4% |
| 2011 | -0.01x | $-20.00 Million | $3.02 Billion | ▼ -111.4% |
| 2010 | 0.06x | $423.00 Million | $7.27 Billion | ▲ +243.8% |
| 2009 | 0.02x | $135.00 Million | $7.97 Billion | ▼ -48.4% |
| 2008 | 0.03x | $319.00 Million | $9.73 Billion | ▼ -16.4% |
| 2007 | 0.04x | $341.00 Million | $8.69 Billion | — |